欧莱雅盯上“早C晚A”先锋？

Group 1 - L'Oréal Group is currently the most competitive acquirer in the potential acquisition of the UK skincare brand Medik8, although both parties have not commented on the rumors [1][2] - Medik8 was founded in 2004 by pharmacologist and biochemist Elliot Isaacs, who introduced the CSA skincare philosophy, which emphasizes using Vitamin C and sunscreen during the day and Vitamin A at night [2][3] - Medik8's sales are projected to grow by 50% in 2024, with expected global revenue reaching approximately $115 million (around 833 million RMB) in 2025, and the brand operates in over 25 countries with products sold in more than 7,000 beauty salons [2][3] Group 2 - Medik8's website has seen a monthly average of over 100,000 visits in 2024, with a 90% year-on-year increase in unique visitors, ranking first in the UK beauty and health website traffic [3] - The brand's parent company, Pangaea Laboratories, received investment from private equity fund Inflection Buyout Fund V in 2021, although the specific amount was not disclosed [3] - Despite its growth, Medik8 currently lacks official online sales channels in China, with its official public account inactive since May 2021 [4] Group 3 - The skincare science sector is becoming increasingly competitive, with L'Oréal Group focusing on expanding its presence in this area through acquisitions and investments [6][8] - In 2024, L'Oréal's skincare division achieved sales of €7.027 billion (approximately 53.241 billion RMB), marking a 9.8% year-on-year increase, making it the fastest-growing segment for the company [6][7] - The global market for adult dermatological skincare products reached $2.295 billion (approximately 16.539 billion RMB) in 2023, with projections to grow to $4.687 billion (approximately 33.777 billion RMB) by 2030, reflecting a compound annual growth rate (CAGR) of 12.3% from 2024 to 2030 [8]